首頁 > 市場調查報告書 > 製藥

藥用輔料市場規模、佔有率和成長分析（按產品類型、功能、配方、原料來源、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1897659

藥用輔料市場規模、佔有率和成長分析（按產品類型、功能、配方、原料來源、最終用戶和地區分類）－2026-2033年產業預測

Pharmaceutical Excipients Market Size, Share, and Growth Analysis, By Product Type (Organic Chemicals, Inorganic Chemicals), By Functionality (Binders, Fillers/Diluents), By Formulation, By Source, By End User, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 175 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球藥用輔料市場規模將達到 101.2 億美元，到 2025 年將達到 108.1 億美元，到 2033 年將達到 182.9 億美元，預測期（2026-2033 年）的複合年成長率為 6.8%。

在藥物研發的進步和對高效穩定製劑日益成長的需求推動下，全球藥用輔料市場正經歷顯著的變革。輔料作為關鍵成分，其作用日益凸顯，不僅能增強藥物療效和遞送效果，還能提高病患的依從性。活性成分的複雜性，尤其是在生物製藥和高效藥物中，促使人們需要能夠促進溶解度、生物利用度和標靶遞送的輔料。市場正擴大使用功能性輔料和共加工輔料來最佳化製劑性能，尤其是在緩釋緩釋性和掩味系統中。奈米技術和3D列印等創新技術為輔料生產商創造了新的機會。此外，監管機構對輔料品質和安全性的日益重視，推動了符合GMP標準的實施，並促進了新型輔料的問世。

全球藥用輔料市場按產品類型、功能、劑型、原料來源、最終用戶和地區進行細分。依產品類型分類，可分為有機化學品、無機化學品和其他。依功能分類，可分為粘合劑、填充劑/稀釋劑、崩壞、包衣劑、潤滑劑、防腐劑、香精/甜味劑、著色劑、溶劑和其他。依製劑形式，可分為口服製劑、外用製劑、注射劑、吸入劑、眼藥水、滴鼻液及栓劑。依原料來源分類，可分為天然來源及合成來源。按最終用戶分類，可分為製藥公司、生物製藥公司、契約製造組織 (CMO) 和合約研究組織 (CRO)。依地區分類，可分為北美、亞太、歐洲、拉丁美洲以及中東和非洲。

全球藥用輔料市場促進因素

全球藥用輔料市場的主要促進因素之一是對能夠提高生物利用度和治療效果的客製化藥物製劑的需求日益成長。隨著製藥業向個人化醫療轉型，對可用於各種給藥系統（包括口服、注射和外用製劑）的專用輔料的需求至關重要。此外，生物製藥產業的快速發展也推動了市場擴張，該產業需要先進的輔料來穩定複雜的生物製藥和生物相似藥。對藥物製劑研發的日益重視正在推動輔料產品的創新，從而創造出有利於市場擴張的動態環境。

全球藥用輔料市場阻礙因素

全球藥用輔料市場的主要限制因素之一是嚴格的法規環境，該環境對藥物製劑中輔料的使用和核准有著嚴格的規定。監管機構對輔料的品質、安全性和有效性制定了嚴格的指導方針和標準，這會增加研發成本並延長產品核可時間。遵守這些法規需要對研發、測試和文件編制進行大量投資，這給希望進入市場的中小型製造商設置了重大障礙。此外，這些法規的複雜性可能會抑制創新，限制新型輔料的供應，進一步限制市場成長機會。

全球藥用輔料市場趨勢

全球藥用輔料市場正經歷著向多功能和共加工輔料的強勁轉變，這主要受效率提升和對創新製劑解決方案的需求所驅動。製藥公司越來越重視那些能夠簡化製劑流程的輔料，這些輔料透過整合關鍵特性（例如增強結合力、崩壞和流動性）來實現這一目標。共加工輔料能夠精細混合多種成分，提供卓越的機械強度和可壓性，從而提高藥片的均勻性和整體產品性能。這一趨勢表明，製藥企業致力於簡化生產流程，在競爭激烈的市場環境中，透過減少生產步驟來開發複雜的劑型。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Glenmark Pharmaceuticals
Ichnos Sciences
Viatris Inc.
Idorsia Ltd.
BASF SE
Evonik Industries AG
Dow Inc.
Ashland Global Holdings Inc.
JRS Pharma
Colorcon, Inc.
Roquette Freres
CP Kelco
Signet Chemical Corporation

結論與建議

簡介目錄

Product Code: SQMIG35H2396

Global Pharmaceutical Excipients Market size was valued at USD 10.12 Billion in 2024 and is poised to grow from USD 10.81 Billion in 2025 to USD 18.29 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global pharmaceutical excipients market is experiencing significant shifts due to advancements in drug development and the heightened demand for effective, stable formulations. Excipients are increasingly recognized as vital components that not only enhance drug efficacy and delivery but also improve patient compliance. The complexity of active pharmaceutical ingredients, particularly in biologics and potent drugs, drives the need for excipients that boost solubility, bioavailability, and targeted delivery. The market is witnessing greater use of functional and co-processed excipients that optimize formulation performance, especially in sustained-release and taste-masked systems. Innovations such as nanotechnology and 3D printing present new opportunities for excipient manufacturers. Additionally, regulatory focus on excipient quality and safety fosters the adoption of GMP-compliant standards and supports new excipient introductions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Excipients Market Segments Analysis

Global pharmaceutical excipients market is segmented into product type, functionality, formulation, source, end user and region. Based on product type, the market is segmented into organic chemicals, inorganic chemicals and others. Based on functionality, the market is segmented into binders, fillers/diluents, disintegrants, coating agents, lubricants, preservatives, flavours and sweeteners, colouring agents, solvents and others. Based on formulation, the market is segmented into oral formulations, topical formulations, parenteral formulations, inhalation formulations, ophthalmic formulations, nasal formulations and suppositories. Based on source, the market is segmented into natural and synthetic. Based on end user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, contract manufacturing organizations (CMOs) and contract research organizations (CROs). Based on region the market is segmented as, North America, Asia Pacific, Europe, Latin America, Middle East and Africa.

Driver of the Global Pharmaceutical Excipients Market

One of the key market drivers for the global pharmaceutical excipients market is the increasing demand for tailored drug formulations that enhance bioavailability and therapeutic efficacy. As the pharmaceutical industry shifts towards personalized medicine, the need for specialized excipients that can accommodate varying drug delivery systems, including oral, injectable, and topical formulations, becomes crucial. Additionally, the burgeoning biopharmaceutical sector, which often requires advanced excipients to stabilize complex biologics and biosimilars, further fuels market growth. The rising emphasis on research and development in drug formulation also propels innovation in excipient products, fostering a dynamic environment conducive to market expansion.

Restraints in the Global Pharmaceutical Excipients Market

One key market restraint for the global pharmaceutical excipients market is the stringent regulatory environment governing the use and approval of excipients in drug formulations. Regulatory agencies impose strict guidelines and standards for quality, safety, and efficacy, which can lead to increased development costs and extended timeframes for product approvals. Compliance with these regulations demands extensive investment in research and development, testing, and documentation, posing a significant barrier for smaller manufacturers seeking to enter the market. Additionally, the complexity of these regulations can hinder innovation and limit the availability of novel excipients, further constraining market growth opportunities.

Market Trends of the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market is witnessing a robust shift towards the adoption of multifunctional and co-processed excipients, driven by the need for enhanced efficiency and innovative formulation solutions. Pharmaceutical companies increasingly prioritize excipients that streamline the formulation process by integrating essential properties such as binding, disintegration, and improved flowability. Co-processed excipients, which entail the microscopic blending of multiple components, offer superior mechanical strength and compressibility, thereby enhancing tablet uniformity and overall product performance. This trend signifies a commitment to simplification in manufacturing, allowing for the development of complex dosage forms while minimizing production steps in an increasingly competitive landscape.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Pharmaceutical Excipients Market Size by Product Type & CAGR (2026-2033)

Market Overview
Organic Chemicals
Inorganic Chemicals
Others

Global Pharmaceutical Excipients Market Size by Functionality & CAGR (2026-2033)

Market Overview
Binders
Fillers/Diluents
Disintegrants
Coating Agents
Lubricants
Preservatives
Flavors and Sweeteners
Coloring Agents
Solvents
Others

Global Pharmaceutical Excipients Market Size by Formulation & CAGR (2026-2033)

Market Overview
Oral Formulations
Topical Formulations
Parenteral Formulations
Inhalation Formulations
Ophthalmic Formulations
Nasal Formulations
Suppositories

Global Pharmaceutical Excipients Market Size by Source & CAGR (2026-2033)

Market Overview
Natural
and Synthetic

Global Pharmaceutical Excipients Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Contract Research Organizations (CROs)

Global Pharmaceutical Excipients Market Size & CAGR (2026-2033)

North America (Product Type, Functionality, Formulation, Source, End User)
- US
- Canada
Europe (Product Type, Functionality, Formulation, Source, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Functionality, Formulation, Source, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Functionality, Formulation, Source, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Functionality, Formulation, Source, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Glenmark Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ichnos Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Idorsia Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BASF SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dow Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ashland Global Holdings Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JRS Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Colorcon, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roquette Freres
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CP Kelco
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Signet Chemical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments